Drug Price Law to Launch New Era in Medicare, Top Official Says

Jonathan Blum was a Senate staffer early in his career when Congress developed the original Medicare Part D prescription drug program.

More than 20 years later, he holds a position at the Centers for Medicare & Medicaid Services that gives him huge influence over the next major iteration of drug pricing policy.

Blum returned to the federal government in 2021 in the middle of the Covid-19 pandemic with a goal of expanding the reach of CMS programs after working in the commercial insurance world.

“What I saw during the last three years with the Covid pandemic” was “a health-care system ...